Trial intelligence / Profile preview

Vitamin C Supplementation in Primary Hypothyroidism

NCT05733078Phase 2Recruiting

Start
Nov 2023
Primary completion
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ascorbic acid in primary hypothyroidism (PH). Started Nov 2023; status: recruiting.

02

Drugs

ascorbic acid
03

Conditions

primary hypothyroidism (PH)

Beyond the preview

Go deeper on NCT05733078.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05733078.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call